Physician profile
Minesh Khatri
NPI 1407056468
$9,697.19
in general payments reported to CMS, 2019-2025
7 companies · $9,604 in 2025
The $9,604 reported for 2025 was more than what 95% of Nephrology (Internal Medicine) providers received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.31 · 2025: $9,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,100 · Food and Beverage: $853 · Travel and Lodging: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,100.00 |
| Food and Beverage | $853.13 |
| Travel and Lodging | $650.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Travere Therapeutics, INC. | $9,231.89 | 2025 | Filspari |
| Astrazeneca Pharmaceuticals LP | $215.11 | 2025 | |
| Apellis Pharmaceuticals, INC. | $97.30 | 2025 | Empaveli |
| Alexion Pharmaceuticals, INC. | $93.31 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.48 | 2025 | |
| Amgen INC. | $20.19 | 2025 | Tavneos |
| Bayer Healthcare Pharmaceuticals INC. | $15.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Minesh Khatri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.